On Monday, Medtronic — a leader in medical technology — announced U.S. commercial availability of MiniMed Connect, a product designed to enable people with diabetes to “discreetly and conveniently” view their insulin pump and continuous glucose monitoring (CGM) information on a smartphone.
MiniMed Connect provides greater convenience for people with diabetes, greater peace of mind for their care partners, and more convenient access to diabetes data for healthcare teams.
According to details shared with mHealthWatch, MiniMed Connect also allows care partners to view and monitor this diabetes information via CareLink Personal, Medtronic’s therapy management software (It delivers preset text notifications to care partners when the person with diabetes experiences sugar levels that go too high or too low or when an alarm on the pump isn’t cleared).
“Effective management of diabetes requires an engaged team of participants, and MiniMed Connect serves to inform and involve people with diabetes, their loved ones and their health care professionals,” said Annette Bruls, President of the Diabetes Service and Solutions business at Medtronic. “Safe and secure sharing of critical diabetes data is an important step for Medtronic as we transform into a holistic diabetes management company.”